Cargando…
Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy
The conventional chemotherapeutic agents, used for cancer chemotherapy, have major limitations including non-specificity, ubiquitous biodistribution, low concentration in tumor tissue, and systemic toxicity. In recent years, owing to their unique features, polymeric nanoparticles have been widely us...
Autores principales: | Rao, N. Vijayakameswara, Ko, Hyewon, Lee, Jeongjin, Park, Jae Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104418/ https://www.ncbi.nlm.nih.gov/pubmed/30159310 http://dx.doi.org/10.3389/fbioe.2018.00110 |
Ejemplares similares
-
Recent Advances in Stimuli-Sensitive Amphiphilic Polymer-Paclitaxel Prodrugs
por: Zhou, Man, et al.
Publicado: (2022) -
Editorial: Stimuli-Responsive Nanoparticles for Anti-cancer Therapy
por: Uthaman, Saji, et al.
Publicado: (2021) -
Recent Progress in European Advanced Therapy Medicinal Products and Beyond
por: Yu, Tracy T. L., et al.
Publicado: (2018) -
Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
por: Chang, Di, et al.
Publicado: (2021) -
Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy
por: Cong, Xiufeng, et al.
Publicado: (2022)